GuideInfectious diseases

COVID-19 vaccine effectiveness against the Delta variant (and current vaccine recommendation)

Summarises the 2021 English study on vaccine protection against Delta and the current CDC vaccination recommendation.

Updated 3 November 2026

When to use it

As historical context on variants and full-course vaccination, and to check who is currently recommended to be vaccinated.

Warning

The Delta variant no longer circulates and the vaccines studied have been replaced by updated formulations: the study is of historical value. The vaccine recommendation summarised is the CDC one as of 23 September 2026.

The study

Lopez Bernal et al. (NEJM, 2021) used a test-negative case–control design including all sequenced symptomatic cases in England while Delta (B.1.617.2) was replacing Alpha (B.1.1.7). They assessed the BNT162b2 (Pfizer-BioNTech) and ChAdOx1 nCoV-19 (AstraZeneca) vaccines.

Keep reading in the app

  • Results (against symptomatic COVID-19)
  • Current recommendation (CDC, 2026–2027 season)
  • Limitations

Practical tip

Main lesson from the study: a single dose gave little protection against Delta; the full course restored most of the protection.

2 more practical tips in the app.

Reference

Official source: CDC: 2026–2027 COVID-19 vaccination guidance

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top